Purpose-Built for Pediatric and Maternal Health.
Backed by the Specialized Expertise These Markets Require.
OPERATING TEAM
We combine the ability to recognize tomorrow's standards of care with the experience to help build the companies that define them.
INVESTMENT ADVISORY TEAM
Dan Burnett, MD, MBA
Venture Partner
CEO Theranova
Pediatric Devices Expert
Ray Muzyka, MD, MBA
Early-Stage Investing
CEO Threshold Impact
Former Bioware
Eve Blossom
Femtech
Venture Strategist
CEO Material Change Institute
CLINICAL & INDUSTRY EXPERTS
Yalda Afshar, MD, PhD
Maternal-Fetal Medicine
Surgeon-scientist, tenured Associate Professor of Maternal-Fetal Medicine at UCLA, Director of Research in Obstetrics and Gynecology, and co-director of UCLA’s Cardio-Obstetrics and Advanced Hemorrhage and Accreta Care Programs.
James Hanson, MD
Healthcare Strategy & Operations Expert
Former VPMA UCSF Benioff Children's Hospital Oakland
Jafar Shenasa
FDA Expert
StartUp Clinicals
Ex FDA Digital Health Center of Excellence
Ahmer Inam
AI Expert
Relanto, Cognisee
Ex Chief AIO, Nike PwC, AI, Xprize
Kimball Wilkins
Reimbursement Expert
Hourglass consulting
Ex VP Digital Experience at Blueshield California
Nick Shah, PhD
Pharma Expert
Stealth Mode Biotech, Ex Nura Bio
Randy E David, PhD, MS
Strategy & Operations
Precision & Population Health
BARDA, Dream Big Health
Gregory Kurio, MD
AI, Pediatric Cardiology Expert
Prolaio, Former Myokardia
Joanne Fedeyko
Femtech
Connection Silicon Valley, Canadian Women's Network
OUR ECOSYSTEM
Born out of Stanford Biodesign, the program brings together clinicians, engineers, entrepreneurs, and experts across the health innovation ecosystem to accelerate high-impact innovations for pediatric and maternal health.
Theranova accelerates development of pediatric medical technologies through engineering, product development, and commercialization expertise.
Children Now advances policies that improve children's health and strengthen the environment for pediatric innovation.
Charrette Advisory serves as a strategic diligence and commercialization partner to Fractal Pediatric Capital, supporting the evaluation of prospective investments across the scientific, clinical, regulatory, reimbursement, market, and adoption factors that ultimately drive value. Charrette also works with Fractal and its portfolio companies to translate these insights into actionable evidence generation, market access, commercialization, and value creation strategies.